# Concord Medical Services Holdings Ltd: Form 20-F for the period ended Dec 31, 2016

- Company: [Concord Medical Services Holdings Ltd](/companies/ccm.md) (CIK 1472072)
- Form: 20-F
- Filed: 2017-05-01
- Accepted by EDGAR: May 1, 2017, 16:07 ET
- Period: 2016-12-31
- Accession: 0001144204-17-023641
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1472072/000114420417023641/v464314_20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1472072/000114420417023641/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2016-01-01 to 2016-12-31 | $65.5m | us-gaap:Revenues |
| Cost of revenue | 12 months, 2016-01-01 to 2016-12-31 | $41.3m | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2016-01-01 to 2016-12-31 | $24.3m | us-gaap:GrossProfit |
| Operating income | 12 months, 2016-01-01 to 2016-12-31 | −$24.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2016-01-01 to 2016-12-31 | $12.9m | us-gaap:InterestExpense |
| Income tax | 12 months, 2016-01-01 to 2016-12-31 | $8.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2016-01-01 to 2016-12-31 | −$37.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2016-01-01 to 2016-12-31 | −$0.29 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2016-01-01 to 2016-12-31 | −$0.29 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2016-01-01 to 2016-12-31 | 130,631,867 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2016-01-01 to 2016-12-31 | −$11.2m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months, 2016-01-01 to 2016-12-31 | $11.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2016-01-01 to 2016-12-31 | $41.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2016-01-01 to 2016-12-31 | $4.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2016-12-31 | $27.4m | us-gaap:Cash |
| Current assets | at 2016-12-31 | $172.1m | us-gaap:AssetsCurrent |
| Total assets | at 2016-12-31 | $465.0m | us-gaap:Assets |
| Current liabilities | at 2016-12-31 | $137.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2016-12-31 | $287.6m | us-gaap:Liabilities |
| Long-term debt | at 2016-12-31 | $31.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2016-12-31 | $11.9m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2016-12-31 | $81.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2016-12-31 | $168.0m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2016-12-31 | 130,091,977 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1472072/000114420417023641/v464314_20f.htm

Filed May 1, 2017.
Source: SEC EDGAR, the filing index for accession 0001144204-17-023641. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.
